Wuhan Easy Diagnosis Biomedicine (002932.SZ) announced that as of November 29, 2024, the company has cumulatively repurchased...
According to Zhitong Finance APP, Wuhan Easy Diagnosis Biomedicine (002932.SZ) announced that as of November 29, 2024, the company has cumulatively repurchased 11.745 million shares through a dedicated repurchase securities account via centralized bidding, accounting for 5.05% of the total share capital; the highest fill price of repurchased shares was 20.98 yuan/share, the lowest fill price was 15.33 yuan/share, and the total transaction amount was 0.224 billion yuan.